Parsons Capital Management Inc Biogen Inc. Transaction History

Parsons Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 26, 2019	SELL	$216.71 - $338.96 $385,743 - $603,348	-1,780 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$278.5 - $352.75 $15,596 - $19,754	56 Added 3.25%	1,780 $536,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $36,395 - $47,594	-124 Reduced 6.71%	1,724 $609,000
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $15,451 - $18,414	60 Added 3.36%	1,848 $0
Q1 2018 May 07, 2018	BUY	$260.13 - $367.91 $3,901 - $5,518	15 Added 0.85%	1,788 $490,000
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $14,151 - $15,850	46 Added 2.66%	1,773 $565,000
Q3 2017 Oct 26, 2017	BUY	$281.15 - $329.69 $485,546 - $569,374	1,727	1,727 $541,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Parsons Capital Management Inc with notifications on news.